⚠ BETA — all market data shown (deals, filings, prices, indices) is demo / illustrative, not live trading data. For evaluation only; verify before acting.
June 16, 2026

NSE

Mankind Pharma LimitedMANKIND

MANKIND₹2,359.8 0.69% today
Nifty Midcap 150

Mankind Pharma is a fast-growing domestic-focused pharma & consumer-health company.

Key productsBranded generics and consumer products (Manforce, Prega News, Gas-O-Fast).
GeographyIndia.
CompetitorsSun Pharma, Alkem, Cipla.

AI-generated overview — verify before relying on it.

Net institutional flow

+445.9 Cr

Institutional buyers

19 in / 1 out

High-impact filings

0 · tilt Neutral

Next corporate action

Competitive landscape — the read

vs mapped peers
Institutional money is backing CIPLA hardest (+1,527.1 Cr net). MANKIND ranks #2 of 9 on flow (net buying +445.9 Cr). Filing momentum favours SUNPHARMA (+2). News & social buzz is most positive on DRREDDY.
#CompanyInst. flow ₹CrDealsHi-impactFiling mom.BuzzNews
1CIPLA+1,527.1 Cr39+1+930
2MANKINDThis+445.9 Cr38
3ALKEM+103.5 Cr33-26
4DRREDDY+0 Cr4+1231
5SUNPHARMA+0 Cr6+2+926
6TORNTPHARM+0 Cr2
7LUPIN+0 Cr4
8ZYDUSLIFE+0 Cr1
9AUROPHARMA+0 Cr2

Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.

Timeline — MANKIND day by day

Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.

Filings that matter

  • 2
    Investor CallNeutral

    Schedule of meet

    Source PDF →
  • 2
    Shareholding DisclosureNeutral

    a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

    Source PDF →
  • 4
    ManagementNeutral

    Cessation of Mr Prateek Dubey as SMP of the company w.e.f.

    Source PDF →
  • 4
    ManagementNeutral

    Appointment of Mr Nilesh Kulkarni as SMP of the company w.e.f.

    Source PDF →
  • 2
    Allotment of SecuritiesNeutral

    allotment of 86778 securities pursuant to ESOP/ESPS at its meeting held on Jun 08, 2026

    Source PDF →

Bulk & block deals

No bulk/block deals for MANKIND in this window.

Results & transcripts

News & chatter on MANKIND

RSS News

0

No recent news.

Google News RSS — links open the source.

The Dispatch

0

No articles yet.

Our coverage.

Reddit

0

No Reddit chatter.

r/ posts mentioning the company.

Twitter / X

0

No posts.

Posts mentioning the company.